DARE
NASDAQ · Pharmaceuticals
Dare Bioscience Inc
$0.64
+0.02 (+2.40%)
Open$0.63
Previous Close$0.62
Day High$0.65
Day Low$0.62
52W High$3.78
52W Low$0.61
Volume—
Avg Volume162.6K
Market Cap12.33M
P/E Ratio—
EPS$-0.79
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+544.8% upside
Current
$0.64
$0.64
Target
$4.12
$4.12
$2.96
$4.12 avg
$5.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.78M | 3.79M | 6.37M |
| Net Income | -23,121,562 | -44,388,664 | 1.14M |
| Profit Margin | -1,300.7% | -1,235.6% | 17.9% |
| EBITDA | -20,565,574 | -41,675,117 | 1.58M |
| Free Cash Flow | — | — | 772.3K |
| Rev Growth | -53.1% | -53.1% | +7.5% |
| Debt/Equity | 2.42 | 2.42 | 0.72 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |